Dermatofibroma and Fibrohistiocytic Lesions
A central white scar-like patch surrounded by a delicate peripheral pigment network defines classic dermatofibroma, with a growing list of atypical variants demanding histopathologic confirmation.
In brief
Dermatofibroma (DF), also called cutaneous fibrous histiocytoma, is the prototypic benign fibrohistiocytic lesion of the skin. The classical dermoscopic signature (central white scar-like patch with a peripheral fine pigment network) was described in the early dermoscopy literature and remains the most useful single criterion in routine practice. However, atypical variants (cellular DF, aneurysmal DF, atypical or pseudosarcomatous DF, deep DF, and lesions with unusual color or surface features) account for a meaningful minority of cases and overlap dermoscopically with melanoma, basal cell carcinoma, atypical fibroxanthoma, and dermatofibrosarcoma protuberans. The diagnostic challenge is to recognize the prototype confidently, recognize the variants as variants, and excise anything that does not fit a pigeonhole.
Must-remember points
Clinical content
01The classical DF presents on the lower extremities of young to middle-aged adults as a firm, slightly hyperpigmented papule with the dimple sign on lateral compression. Dermoscopically, a central white scar-like patch (corresponding to dermal fibrosis with reduced epidermal melanin) sits within a delicate, regular peripheral pigment network (corresponding to acanthotic rete ridges with basal hypermelanosis). Zaballos's foundational study of 412 lesions identified ten dermoscopic patterns: the prototype (central white plus peripheral network) accounted for the largest share, with multiple peripheral white patches, central white network, and homogeneous brown patches as the next most frequent variants.
02The dimple sign (Fitzpatrick sign) is a clinical feature with dermoscopic correlates. Lateral compression of the lesion produces inward depression because the dermal fibrosis tethers the overlying epidermis. Under dermoscopy, the same maneuver may reveal the white scar-like center moving with the dermis rather than sliding over it. The sign is highly specific but not pathognomonic: deep DF and some scars can produce similar tethering.
03Atypical dermatofibromas form a heterogeneous group. Cellular DF is histopathologically more cellular than classic DF and clinically larger, sometimes ulcerated; dermoscopically it often shows polymorphic vessels, central red-blue homogeneous areas, and may lack the typical white patch. Aneurysmal DF (also called hemosiderotic) contains pseudovascular blood-filled spaces and may appear as a blue, purple, or even nodular dark-red lesion clinically; dermoscopically it often shows red-blue or purple lacunar areas resembling angiokeratoma or vascular malformation. Atypical (pseudosarcomatous) DF carries minor histopathologic atypia (occasional mitoses, mild pleomorphism) but behaves benignly; it may show unusual dermoscopic features but is most often diagnosed on histology after excision of an unusual lesion.
04Epithelioid cell histiocytoma (also called epithelioid fibrous histiocytoma) is now recognized as a distinct entity rather than a DF variant. It typically presents as a polypoid or pedunculated reddish papule on the lower extremity, sometimes with a collarette. Dermoscopically it shows red-pink homogeneous areas, polymorphic vessels, and absence of the classic DF features. The 2015 discovery of recurrent ALK gene rearrangements (most often SQSTM1-ALK and VCL-ALK; also DCTN1, PRKAR2A, and ETV6 partners) cemented the entity as biologically distinct, and ALK immunohistochemistry is now part of the differential workup. Recently, ROS-1 fusions and rare FN1-EGFR rearrangements have also been described in cases with epithelioid morphology.
05Deep DF (fibrohistiocytoma profundum, deep benign fibrous histiocytoma) is a rare subcutaneous variant that presents as a firm subcutaneous nodule, usually larger than classic DF, with a higher recurrence rate (about 20% locally) and a preference for the head, neck, and lower extremity. Dermoscopy is limited because the lesion is mainly subcutaneous; surface findings are non-specific (homogeneous skin-color or pink with telangiectasia). Imaging or excisional biopsy is usually required. The differential includes dermatofibrosarcoma protuberans (DFSP), schwannoma, neurofibroma, and lipoma.
06Dermatofibroma in darker skin (Fitzpatrick IV-VI) shows several distinctive features. Pigment is more intense, the peripheral network appears thicker and darker, and the central white patch may be partly obscured by background hyperpigmentation. Postinflammatory hyperpigmentation often surrounds the lesion. The dimple sign and palpable firmness remain reliable across phototypes. Clinically, hypertrophic and keloidal DFs are more common in darker skin and on the chest and back.
07Polypoid and pedunculated DFs occur on the lower extremities, perianal region, and rarely the trunk. They differ from classic DF in shape (raised, sometimes stalked) but retain the dermoscopic vocabulary of central white plus peripheral network when the lesion is photographed obliquely. Lentiginous border (a darkly pigmented periphery resembling a solar lentigo or junctional nevus) is a recognized variant pattern, and the lesion can simulate a melanocytic neoplasm at first glance. Thick, dark, slightly irregular network may shade into atypical network and trigger excision when the central scar-like patch is incomplete.
08Differential diagnosis is the central skill. Atypical fibroxanthoma (AFX) presents on chronically sun-damaged scalp or face of older patients as a rapidly growing red nodule, often ulcerated, with polymorphic vessels and white shiny structures; the absence of the DF prototype features and the actinic context separate the two. Basal cell carcinoma in pigmented form may show a white shiny patch but adds arborizing vessels, blue-grey ovoid nests, leaf-like areas, or spoke-wheel structures. Melanoma rarely mimics DF, but lesions with white scar-like areas plus atypical network, multiple colors, or atypical vessels deserve excision; the rule is that any DF-like lesion that does not fully fit the prototype should be biopsied. ROS-1 positive epithelioid fibroblastic tumors and other emerging fusion-driven entities are increasingly recognized in atypical cases and may require molecular workup.
Key dermoscopic features
High yield clinical points15 pearls in 3 groups
Recognition & pattern analysis
4 pointsPitfalls & mimics
8 pointsWhen to biopsy
3 pointsLectures covering this topic5 lectures
Notable updates & conceptual milestones5 updates
Ten-pattern dermoscopic classification
2008Zaballos's 2008 study of 412 dermatofibromas defined ten distinct dermoscopic patterns and quantified their frequency, providing the empirical basis for routine pattern recognition.
ALK-rearranged epithelioid cell histiocytoma
2016Recurrent ALK fusions (most often VCL-ALK and SQSTM1-ALK) were identified in 2016 as defining molecular events in epithelioid cell histiocytoma, separating it from classic DF and motivating ALK immunohistochemistry in the workup.
ROS-1 and FN1-EGFR fusions in fibrohistiocytic spectrum
2021Recent case series have described ROS-1 fusion-positive epithelioid fibroblastic tumors and rare FN1-EGFR rearrangements, expanding the molecular landscape of cutaneous fibrohistiocytic neoplasms beyond classical DF.
Dimple sign as bedside-dermoscopy crosswalk
2010Combining the classical dimple sign on lateral compression with dermoscopic verification of the central white patch tethered to the dermis raises diagnostic confidence in equivocal cases, particularly in dark skin where the network may be obscured.
Recognition of aneurysmal DF as melanoma mimic
2012Aneurysmal (hemosiderotic) DF was repeatedly highlighted in the dermoscopy literature as a melanoma mimic because of its red-blue or purple lacunae, polymorphic vessels, and occasional asymmetric pigmentation. Awareness drives excision rather than monitoring of equivocal blue-purple firm lesions.
Bottom line
When the lesion is a firm leg papule with a central white scar-like patch, a fine peripheral network, and a positive dimple sign, dermatofibroma is confidently diagnosed and observation is appropriate. Anything that deviates from this prototype (cellular, aneurysmal, deep, atypical, polypoid, lentiginous, or unusual site) should be excised because the differential includes melanoma, AFX, BCC, DFSP, and emerging fusion-driven entities.
Molecular characterization will continue to subdivide the fibrohistiocytic spectrum. ALK-positive epithelioid cell histiocytoma is the established example, ROS-1 fusion-positive epithelioid fibroblastic tumors are an emerging cohort, and routine fusion panels in atypical fibrohistiocytic lesions will likely identify additional entities with prognostic and therapeutic relevance.
References
Sources cited in the lecture content or that underpin the clinical points above. Verify with primary sources before practice changes.
- [1]Zaballos P, Puig S, Llambrich A, Malvehy J. Dermoscopy of dermatofibromas: a prospective morphological study of 412 cases. Arch Dermatol 2008;144:75-83.PubMed: 18209171DOI: 10.1001/archdermatol.2007.8· Foundational ten-pattern classification underpinning routine DF dermoscopy.
- [2]Ferrari A, Argenziano G, Buccini P, et al. Typical and atypical dermoscopic presentations of dermatofibroma. J Eur Acad Dermatol Venereol 2013;27:1375-1380.PubMed: 23176079DOI: 10.1111/j.1468-3083.2012.04676.x· Documented atypical DF subtypes (cellular, aneurysmal, lentiginous border) and their dermoscopic features.
- [3]Doyle LA, Marino-Enriquez A, Fletcher CD, Hornick JL. ALK rearrangement and overexpression in epithelioid fibrous histiocytoma. Mod Pathol 2015;28:904-912.PubMed: 25857825DOI: 10.1038/modpathol.2015.49· Defining paper on ALK fusions establishing epithelioid cell histiocytoma as a distinct entity from classic DF.
- [4]Agaimy A, Tirado CA, Laskin WB, et al. Recurrent novel HMGA2-NCOR2 fusions characterize a subset of keratin-positive giant cell-rich soft tissue tumors. Mod Pathol 2021;34:1507-1520.PubMed: 33742141DOI: 10.1038/s41379-021-00789-8· Example of expanding fusion-driven landscape in cutaneous and soft tissue fibrohistiocytic neoplasms.
- [5]Han TY, Chang HS, Lee JH, Lee WM, Son SJ. A clinical and histopathological study of 122 cases of dermatofibroma (benign fibrous histiocytoma). Ann Dermatol 2011;23:185-192.PubMed: 21747617DOI: 10.5021/ad.2011.23.2.185· Clinicopathologic series with site distribution and histologic subtypes including deep variants.
- [6]Bakos RM, Cartell A, Bakos L. Dermatoscopy of early-stage dermatofibrosarcoma protuberans. J Eur Acad Dermatol Venereol 2018;32:e285-e286.PubMed: 29377285DOI: 10.1111/jdv.14808· Differential dermoscopy distinguishing DFSP from deep DF and other fibrohistiocytic mimics.
- [7]Arpaia N, Cassano N, Vena GA. Dermoscopic patterns of dermatofibroma. Dermatol Surg 2005;31:1336-1339.PubMed: 16188191DOI: 10.1111/j.1524-4725.2005.31213· Earlier series corroborating the central white patch plus peripheral network prototype.